Moderate expansion in laboratory volumes expected next year
56% expect volumes will increase by one to five percent
Projected expansion attributed to marketing efforts and increased in-house capacity A challenging government reimbursement drives labs to place emphasis on cost reduction
55% expect the Protecting Access to Medicare Act of 2014 (PAMA) to have a negative revenue impact on their lab
58% said that cost reduction is their leading strategic priority, and the #1 factor impacting supply budgets
56% say they have reduced their supply budgets over the last year
Please note: the online download version of this report is for a global site license.